Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report)’s stock price gapped up prior to trading on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $22.00 to $24.00. The stock had previously closed at $18.81, but opened at $19.55. JPMorgan Chase & Co. currently has a neutral rating on the stock. Bath & Body Works shares last traded at $19.7550, with a volume of 677,864 shares traded.
A number of other equities research analysts have also weighed in on the company. Morgan Stanley reissued an “equal weight” rating and issued a $22.00 target price on shares of Bath & Body Works in a research note on Monday, July 6th. The Goldman Sachs Group downgraded Bath & Body Works from a “neutral” rating to a “sell” rating and lowered their price objective for the company from $23.00 to $19.00 in a research report on Wednesday, July 8th. TD Cowen raised their target price on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Weiss Ratings upgraded shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. Finally, Jefferies Financial Group increased their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Four research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Bath & Body Works currently has an average rating of “Hold” and an average price target of $22.57.
Check Out Our Latest Research Report on BBWI
Institutional Inflows and Outflows
Bath & Body Works Trading Up 6.5%
The company’s 50 day moving average is $20.38 and its 200-day moving average is $20.14. The company has a market capitalization of $4.04 billion, a P/E ratio of 5.61, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. During the same period in the previous year, the firm posted $0.49 EPS. The business’s revenue for the quarter was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Analysts predict that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Friday, August 21st. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Further Reading
- Five stocks we like better than Bath & Body Works
- Berkshire Just Made a Huge Alphabet Bet—Should You Follow?
- Michael Burry Is Betting Against Palantir Again—Should Investors Care?
- Fabrinet’s Sell-Off May Prove It Is One of AI’s Most Misunderstood Stocks
- Orbiting Wealth: Institutions Load Up SpaceX
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
